Transcript File

Has little therapeutic value
Has multiple actions
Has short t ½
Activates muscarinic & nicotinic receptors
4/9/2017
1
Muscarinic stimulation:
On the CVS:
-ve chronotropic & inotropic effects
Decrease stroke volume & cardiac output
Decrease ABP:
Stimulation of vascular M3 receptors
Increase NO release from endothelium
4/9/2017
2
Eye:
Miosis:
Contraction of circular muscle of iris
Accommodation to near vision:
Contraction of ciliary muscle of the eye
Decrease IOP( intra-occular pressure)
4/9/2017
3
Exocrine glands & GI secretion:
Increase secretion
Contraction of intestinal wall & relaxation of
sphincters:
Defecation
Contraction of bladder wall & relaxation of sphincter:
Urination
4/9/2017
4
 Bronchi:
Bronchoconstriction
Increase mucosal secretion
Penile erection:
Increase release of nitric oxide
4/9/2017
5
Nicotinic receptor stimulation:
Autonomic ganglia:
Stimulation
Adrenal medulla:
Increase noradrenaline & adrenaline secretion
NM Junction transmission:
Muscle contraction
4/9/2017
6
Mimic or simulate actions of Ach:
Direct-acting
Indirect-acting
4/9/2017
7
Activate directly cholinergic receptors:
Choline esters:
Bethanechol, Carbachol, Methacholine
Resist degradation by cholinesterases
Have longer duration of action than Ach
Natural alkaloid:
Pilocarpine
Acts directly on end organs like the eye
4/9/2017
9
Derivative of Ach
Has:
Little nicotinic effects
Good muscarinic effects on bladder & GIT
Leads to easy urination & defecation
Used to treat post-operative or post-labour:
Urinary retention or paralytic ileus: the weakness of intestine
to push its content causing constipation because of weak
peristaltic activity
4/9/2017
13
Derivative of Ach
Has muscarinic & nicotinic actions
Limited use:
Because of nicotinic effects on ganglia & adrenal medulla
Used mainly topically as miotic in glaucoma to
decrease high intraocular pressure (IOP)
4/9/2017
14
Natural plant alkaloid
Resistant to CE enzyme
It produces:
Miosis (contraction of circular muscle of iris)
Contraction of ciliary muscle of the eye
Reduction of IOP
Used topically in glaucoma
4/9/2017
15
Lowers high IOP in close-angle & open angle chronic
glaucoma
Improves outflow of aqueous humour:
Opens fluid pathway
Increase aqueous flow through canal of Schlemm
Secondary to contraction of circular muscle of the iris & ciliary
muscle
Stimulates sweating, lacrimation, salivation
4/9/2017
16
4/9/2017
17
Paralytic ileus (Bethanechol)
Urinary retention (Bethanechol)
Glaucoma (Pilocarpine & Carbachol topically
Xerostomia (dry mouth) of Sjogren’s syndrome
(oral pilocarpine)
4/9/2017
19
Excessive sweating, salivation
Flushing, hypotension
Abdominal colic & diarrhoea
Bronchospasm
Pilocarpine:
Impaired accommodation to far vision & darkness
4/9/2017
21
 Bronchial
asthma
 Peptic ulcer
4/9/2017
22
 CE
is a protein
In cholinergic synapses & RBC
Metabolizes Ach into choline & acetate
Specific for Ach in cholinergic synapses
 Pseudocholinesterase
in plasma & liver
Not specific to Ach
Metabolizes other drugs (suxamethonium, procaine)
23
Classified into:
 Reversible
cholinesterase inhibitors
 Irreversible cholinesterase inhibitors
24
 Diagnosis
of MG (Edrophonium)
 Treatment of MG (Pyridostigmine)
 Reversible
NMB intoxication (Neostigmine)
 Alzheimer’s disease (Donepezil)
 Irreversible
CEI: insecticides
25
Autoimmune (autoantibodies to NM in NMJ)
Reduction in receptor number
Muscle weakness, fatigability,, difficult speaking &
swallowing
Treatment:
Reversible CEI
Thymectomy
Immunosuppressant
26
 Inhibit
reversibly CE enzyme
 Accumulation of Ach
 Electrostatic bonds
 Stimulate nicotinic & muscarinic receptors
 Useful in myasthenia gravis
27
Synthetic CEI, does not cross BBB
Duration of action (4 hrs)
Mainly in MG & also in:
Antidote to competitive NM blocker tubocurarine poisoning
Paralytic ileus, urinary retention
Given orally, SC
28
 Similar
to neostigmine
 Has longer duration of action (6 hrs)
 Useful orally in myasthenia gravis
29



Over-stimulating of nicotinic receptors can cause
muscle weakness and paralysis by the excessive
intake ofAnticholinesterases which are (indirect
drugs)
Over-stimulation of nicotinic receptors will lead to
its blockage instead of further activation.
Cholinergic crisis can happen to myasthenia
gravis patients who are overdosing on
anticholinesterases drugs.
Similar to neostigmine
IV, short duration of action (10-20 min)
Useful in diagnosis of MG
To differentiate between weakness due to myasthenic
crisis or cholinergic crisis:
Myasthenic crisis
Cholinergic crisis
improvement
aggravated
31
 Excessive
salivation
 Flushing and hypotension
 Abdominal colic and diarrhoea
 Bronchospasm
32
 Tacrine
Reversible CEI used in treatment of Alzheimer’s disease;
hepatotoxic
 Donepezil
New selective CEI
Once daily
Lacks hepatoxicity of tacrine
Useful in Alzheimer’s disease
33
Organophosphorous compounds
Irreversibly inhibit CE
Covalent bond in Enzyme-inhibitor complex
Used as insecticides:
Parathion, malathion
As nerve gases in chemical warfare:
Tabun, Sarin, Soman
34
 OP
compound
 Irreversibly inhibits CE
 Insecticide
 Toxicity: excessive cholinergic stimulation
 May be used topically in glaucoma
 Duration of action about a week
35
 New
agent
 Similar to isoflurophate
 Long duration of action (week)
36
Actions on receptors:
Direct
Indirect
Pharmacodynamic effects:
Similar
Central effects with indirect:
Cross BBB
37
 Agricultural
or industrial accidents
 Excessive cholinergic manifestations
 GIT (diarrhoea, colic)
 Respiratory (dyspnoea, bronchospam)
 CV (bradycardia, hypotension)
 Micturition, excessive sweating, M. paralysis
 Miosis (pin-point pupil), convulsions & death
38
 General
measures
 High doses atropine IV or IM
 Mechanical ventilation
 Diazepam for convulsions
 Enzyme reactivation by pralidoxime IM
39


a)
b)
Anti-muscarinic drug: Atropine-like drugs, Hyoscine
(Scopolamine)
Anti-nicotinic drugs
Ganglion
blockers:
Used
in
experimental
pharmacology. E.g. Nicotine, Trimethapan.
Neuro-muscular blockers: Used in surgery to produce
complete muscle relaxation.

•

•

•
Natural agents:
Atropine, Hyoscine
Semi-synthetic
Homatropine
Synthetic
Ipratropium, Pirenzepine, Propantheline

Atropine (Hyoscyamine)
•
Alkaloids obtained from Atropa Belladona,
Considered as prototype for parasympatolytics

Hyoscine (Scopolamine)
•
•
Obtained from Hyocyamus niger plant (Datura
Stramonium)
Note: Antihistamines, phenothiazides and
some
antidepressants
have
antimuscarinic effects
Mechanism of action:




Reversible blockade of M receptors
Exocrine glands are most sensitive
Gastric secretion is the least affected
Heart is intermediate
Note: Atropine blocks all 3 subtypes receptors
(M1,M2,M3)
Absorption:
 Natural and most tertiary amines: good
 Wide distribution and cross BBB
 Quaternary amines: poorly absorbed and poor
crossing BBB (Ipratropium)
 Atropine t½: 2hrs
 Partly metabolized and partly excreted unchanged

 Exocrine
•
•
•
glands: at low doses reduced
secretions
Salivary
Bronchial
Sweet glands




Central stimulant effects (Atropine)
Some may produce sedation (Hyoscine)
Hyoscine blocks M receptors in vomiting centre and
has anti-emetic effect
Toxic doses: hallucination, convulsion, coma
Mydriasis
(dilatation of pupil)
Cycloplegia (relaxation of the ciliary muscle) cause:
blurred vision and impaired accommodation to near
vision
Decreased lacrimation
Increase IOP
Depending in the doses
 Central effect:
 Decrease heart rate
 Peripheral effect:
 Blockade of vagus nerve and increase heart rate
 ABP:
 No change



Bronchodilatation
Reduced bronchial secretion
Ipratropium (quaternary amine derivate of Atropine)
inhalation:
◦ Useful in asthma and chronic obstructive pulmonary
disease (COPD), also in patient who are unable to take
adrenergic agonists.






Decrease salivation
Decrease acid secretion
Decrease motility
Delay gastric emptying
Prolong intestinal transit time
Anti-diarrhoeal
and
anti-spasmodic
effects



Relaxation of bladder wall
Useful in inflammatory spasm and pains of the
urinary tract
Risky in patients with BPH (Benign Prostatic
Hypertrophy)
CNS disorders:
 Parkinson’s disease
 Drug-induced parkinsonism as Phenothiazine
(induced acute dystonias: sustained contraction of
muscles leading to twisting, distorted postures)
 Benztropine, Benzhexol: useful
 Motion sickness: Hyoscine oral, injection, transdermal patches
Ocular uses:
 In
eye examination (Tropicamide) produce
mydriasis and cycloplegia
 In iritis (Atropine eye drop) prevent synechia
(adhesion of the iris to the lens)
Note:
 Atropine eye drops effects: 7 days
 Tropicamide eye drops effects: 4-12hrs


Premedication: Hyoscine and Atropine (use as
adjunct in anaesthetic procedure)
Bronchial asthma: Ipratropium inh. (produce
bronchodilatation)
Cardiovascular:
 Bradycardia
and
Atropine
heart
block
following
AMI:
GI disorders:
 Anti-diarrhoeal
• Lomotil= atropine + diphenoxylate
 Anti-spasmodics (in intestinal colic, irritable
bowel syndrome)
• Atropine, hyoscine, clidinium, prifinium.
Urinary disorders:
 Urinary urgency with UTI
 Renal colic
 Cholinergic poisoning as:
• Irreversible CEI insecticide poisoning
• Chemical warfare intoxication.
 To counteract muscarinic effects
 (nicotinic effects can not be reversed)
 Atropine IV





Dry mouth
Blurred vision
Tachycardia
Constipation
Hot flushed dry skin & hyperthermia may occur
with high doses
Glaucoma
• Increase IOP
BPH
• Bladder wall relaxation & sphincter
contraction




Hot flushed dry skin & hyperthermia,
Agitation, delirium, hallucination,
Convulsions & coma
Treatment is symptomatic
 Atropine
 Hyoscine
• Buscopan
 Clidinium
• Libraxam
 Prifinium
• Riabal

Nondepolarizing (competitive)
blockers

The first drug known to block the
skeletal NMJ was curare.
Neuromuscular blockers are
clinically useful during surgery to
facilitate tracheal intubation and
provide complete muscle
relaxation at lower anesthetic
doses, allowing for more rapid
recovery from anesthesia and
reducing postoperative respiratory
depression.


Depolarizing agents

Depolarizing blocking
agents work by
depolarizing the plasma
membrane
of the muscle fiber,
similar to the action of
ACh.
